HomeNDC LookupIngredientsCalcium Polycarbophil › 70677-1083-01
Foster and Thrive Fiber Laxative 147 Calcium polycarbophil 625 mg Tablet, 90-count — NDC 70677-1083-01 package photo

Foster and Thrive Fiber Laxative 147 Calcium polycarbophil 625 mg Tablet, 90-count

by Strategic Sourcing Services LLC · 90 TABLET in 1 BOTTLE (70677-1083-1)
NDC 70677-1083-01
🏷️ FDA NDC (as labeled) 70677-1083-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 70677-1083-1
Product NDC 70677-1083
11-digit billing NDC 70677108301
NCPDP billing unit EA — each (per item)
RxCUI 308934
UNII 8F049NKY49
Application # M007
SPL Set ID 88d341a6-28aa-4a20-bfed-1d5f3106c2ae
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-06-15
Route ORAL
Dosage form TABLET
Substance CALCIUM POLYCARBOPHIL
GPI-14 46300020100310
GCN Seq No 003065
GCN 08342
HICL code 001346
Ingredient (HICL) Calcium Polycarbophil
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FT FIBER LAXATIVE 625 MG CPLT
FDB brand name Fiber Laxative
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 70677-1083-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1083-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Bulk-forming laxatives class.

Drug family (ATC) Bulk-forming laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedJun 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name FT FIBER LAXATIVE 625 MG CPLT Ingredient Calcium Polycarbophil
🧪 What is this product?

Foster and Thrive Fiber Laxative is an over-the-counter tablet taken by mouth. It contains calcium polycarbophil, a type of bulk-forming fiber commonly used to relieve occasional constipation by absorbing water in the intestines and increasing stool volume. This is an OTC monograph product, meaning it is marketed under established FDA guidelines for laxative products rather than through individual drug approval.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color White
ShapeOval
ImprintG147
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H0G9379FGK
    Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
  • UNII T9D99G2B1R
    Caramel is a brown coloring substance made by heating sugar. It's added to medicines to give them color and sometimes a slight sweet taste without affecting how the drug works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 368GB5141J
    A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescalcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.058 $5.26 / 90 tablets
Medicaid paysCMS SDUD · 12 mo $0.1890 $17.01 / 90 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Dec 2025 Apr 2026 Aug 2026 $0.065 $0.058
▼ Down 8% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fiber Lax 625 mg 00536-4306-05 Rugby 500 tablets $0.058 Availability likely
Fiber Tabs 625 mg 00904-2500-91 Major 90 tablets $0.058 Availability likely
Calcium Polycarbophil 625 mg 70000-0067-01 LEADER/ 250 tablets $0.058 Availability likely
Foster and Thrive Fiber Laxative 147 625 mgthis 70677-1083-01 Strategic 90 tablets $0.058 Availability likely
Fiber caplets 147 625 mg 83324-0131-90 Chain 90 tablets $0.058 Availability likely
Walgreen Fiber Lax 625 mg 00363-0120-14 WALGREENS 140 tablets FDA listed
up and up fiber therapy 625 mg 11673-0620-90 Target 140 tablets FDA listed
Rite Aid Fiber Caplets 625 mg 11822-2025-00 RITE 250 tablets FDA listed
Fiber Caplets 625 mg 21130-0021-40 SAFEWAY 140 tablets FDA listed
Good Neighbor Pharmacy Fiber-Caps Fiber Laxative Stimulant Free 625 mg 24385-0125-27 Amerisourcebergen 90 capsules FDA listed
Fiber Caplets 625 mg 30142-0132-14 THE 140 tablets FDA listed
Fiber Laxative 625 mg 36800-0465-27 Topco 90 tablets FDA listed
Fiber Laxative 625 mg 41163-0147-94 UNITED 140 tablets FDA listed
Publix 625 mg 41415-0021-90 PUBLIX 90 tablets FDA listed
Fiber Therapy 625 mg 49035-0147-94 Wal-Mart 140 tablets FDA listed
Goodsense Fiber laxative 147 625 mg 50804-0147-94 GoodSense 140 tablets FDA listed
Fiber Caps 625 mg 53041-0147-27 Guardian 90 tablets FDA listed
Fiber laxative 625 mg 53943-0147-27 Discount 90 tablets FDA listed
Fiber Laxative 625 mg 54257-0379-07 Magno-Humphries, 90 tablets FDA listed
Fiber Laxative 625 mg 54257-0479-07 Magno-Humphries, 90 tablets FDA listed
Fiber Lax 625 mg 55289-0949-30 PD-Rx 30 tablets FDA listed
Fiber Laxative 625 mg 57896-0459-09 Geri-Care 90 tablets FDA listed
Calcium Polycarbophil 625 mg 58624-5003-01 SHANDONG 90 tablets FDA listed
Quality Choice 625 mg 63868-0530-90 QUALITY 90 tablets FDA listed
Best Choice 625 mg 63941-0023-90 BEST 90 tablets FDA listed
Premier Value 625 mg 68016-0220-25 PHARMACY 250 tablets FDA listed
Calcium Polycarbophil 625 mg 69842-0846-02 CVS 250 tablets FDA listed
Calcium Polycarbophil 625 mg 70369-0006-08 CITRAGEN 120 tablets FDA listed
Amazon Fiber Caplets 625 mg 72288-0201-40 AMAZON.COM 140 tablets FDA listed
Fiber Laxative Caplets 625 mg 77333-0120-50 Gendose 50 tablets FDA listed
Meijer Fiber Caplets 625 mg 79481-1205-00 MEIJER 250 tablets FDA listed
Fibercon 625 mg 80070-0500-14 Foundation 140 tablets FDA listed
Quality Choice Fiber Caplets 625 mg 83324-0276-14 QUALITY 140 tablets FDA listed
Equalactin Laxative 625 mg 69846-0000-26 NUMARK 24 tablets Discontinued
Fibercon 625 mg 63029-0170-14 Medtech 140 tablets FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Jun 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1083-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
670
Units reimbursed last 4 qtrs
44.7K
Gross reimbursed last 4 qtrs
$8.5K
Avg / prescription
$12.61
Avg / unit
$0.1890
Latest quarter Q1 2026
160Rx
Medicaid pays / ea
$0.1890
gross reimbursed
vs
NADAC / ea
$0.0584
acquisition cost
=
Spread
+$0.1306
+224% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
70% FFS 30% MCO
Fee-for-service · 466 Rx Managed care · 204 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 2,282 units · 39.8 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 9,978 units · 51.0 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 288 units · 2.4 per 100k residents OH Pennsylvania: 1,499 units · 11.6 per 100k residents PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 21,756 units · 55.8 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 5,971 units · 302 per 100k residents NE Missouri: no data reported MO Kentucky: 2,940 units · 65.0 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
2.4302
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Nebraska 302 /100k
2 Kentucky 65.0 /100k
3 California 55.8 /100k
4 New York 51.0 /100k
5 Minnesota 39.8 /100k
6 Pennsylvania 11.6 /100k
7 Ohio 2.4 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70677-1083-01 You're viewing this 90 TABLET in 1 BOTTLE (70677-1083-1) 2023-06-15 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 15 words

USE(S) relieves occasional constipation this product generally produces bowel movement in 12 to 72 hours

⏱️ Dosage and Administration 80 words

DIRECTIONS take this product (child or adult dose) with a full glass or water (8oz.) or other fluid. Taking this product without enough liquid may cause chocking. See choking warning. dosage will vary according to diet, exercise, previous laxative use or severity of constipation continued use for 1 to 3 days is normally required to provide full benefit adults and children 12 years and over 2 caplets, 1 to 4 times a day children under 12 years ask a doctor

⚠️ Warnings 54 words

WARNINGS Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

📦 Storage and Handling 16 words

OTHER INFORMATION each caplet contains: calcium 135 mg store at room temperature protect contents from moisture

🧪 Active Ingredient 14 words

ACTIVE INGREDIENT (in each caplet) Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil

🧪 Inactive Ingredients 20 words

INACTIVE INGREDIENTS calcium carbonate, caramel, colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium lauryl sulfate.

🎯 Purpose 3 words

PURPOSE Bulk-forming laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.